DOJ Intervenes in Case Alleging Submission of Inflated Diagnostic Info to Medicare
The DOJ has intervened in a qui tam FCA suit against Independent Health Corporation, DxID LLC, and former DxID CEO Betsy Gaffney, alleging they submitted inaccurate information about the health status of beneficiaries enrolled in Medicare Advantage Plans, to increase Independent Health’s reimbursement.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year